PNC-27
LIMITED EVIDENCEAlso known as: p53-derived peptide
Investigational — not approved for human use
Educational Overview
A peptide derived from a p53 domain fused to a membrane-penetrating sequence, studied in cancer cell-line research.
Research Mechanism
Studied for selective membrane disruption of cells overexpressing HDM-2 in in-vitro cancer models.
Areas of Study
- Cancer cell-line research (in vitro)
Safety Considerations
Human safety is not established. No controlled human evidence exists. This material must not be represented as a cancer treatment. Research material only.
Frequently Asked Questions
Is this approved for human use?
No. This material is supplied for laboratory research use only by qualified businesses and institutions. It is not a medicine and is not for human or veterinary consumption.
How do I get pricing?
Request a quote and our team will respond with current pricing and available sizes for your account.
Do you provide purity documentation?
Certificates of analysis are available to approved accounts. Contact our team for batch-specific documentation.
References
References pending editorial review
We publish citations only after a qualified reviewer has verified them against the primary literature. We do not list references we have not checked. (1 queued.)
Last reviewed: 2026-07-23 · Status: in_review · References verified by editorial review before publication.
Disclaimer: Educational only. Not medical advice, diagnosis, or treatment. For research and educational purposes. Consult a licensed medical professional.